media_press_banner.jpg
Monday, October 24, 2011

Similar remission results shown between once-daily 4g dose and twice-daily 2g doses of mesalazine (PENTASA®) in active ulcerative colitis

|Read Press Release|
Thursday, October 20, 2011

Ferring Pharmaceuticals acquires Cytokine PharmaSciences Inc.

|Read Press Release|
Friday, September 02, 2011

The untold impact of childhood bedwetting in later life

|Read Press Release|
Friday, September 02, 2011

New research reveals night-time toilet trips are not a trivial problem

|Read Press Release|
Wednesday, August 31, 2011

New data demonstrating long-term benefits of FIRMAGON® (degarelix) for advanced hormone-dependant prostate cancer published in The Journal of Urology

|Read Press Release|
Wednesday, July 06, 2011

MEGASET Study demonstrated effectiveness and tolerability of MENOPUR® after ICSI in GnRH antagonist cycles

|Read Press Release|
Monday, March 21, 2011

Ongoing extension study results provide further evidence for first-line use of FIRMAGON® (degarelix) in advanced prostate cancer

|Read Press Release|
Monday, January 17, 2011

SMC Announces Acceptance of Degarelix (FIRMAGON®▼)for use within NHS Scotland

|Read Press Release|
Tuesday, June 01, 2010

Extension study with FIRMAGON® (degarelix) showed continued benefits for prostate cancer patients beyond one year

|Read Press Release|
Monday, May 10, 2010

Ferring acquires LYSTEDA™ from Xanodyne Pharmaceuticals, Inc.

|Read Press Release|
Monday, April 19, 2010

Consider the "whole-man" when treating prostate cancer

|Read Press Release|
Monday, April 19, 2010

Wake Up to Nocturia - Studies Reinforce Serious Associated Risk of Nocturia

|Read Press Release|
Thursday, April 01, 2010

Xanodyne and Ferring announce co-promote for ZIPSOR™

|Read Press Release|
Monday, December 21, 2009

FIRMAGON® has a significantly greater probability of PSA recurrence-free survival than leuprolide in prostate cancer patients

|Read Press Release|
Friday, July 31, 2009

Ferring donates $3 million to the royal textile academy of Bhutan

|Read Press Release|
Tuesday, June 30, 2009

Ferring launches New International Fertility Media Award (FIMA) 2010

|Read Press Release|
Tuesday, June 30, 2009

New Data Supports Significant Economic and Clinical Value of MENOPUR® in IVF

|Read Press Release|
Tuesday, June 30, 2009

Ferring Research Infertility and Gynaecology GrAnt (FRIGGA)

|Read Press Release|
Thursday, April 02, 2009

Ferring Pharmaceuticals announces new Board Member

|Read Press Release|
Wednesday, March 25, 2009

Frost & Sullivan Accolade for Ferring Pharmaceuticals

|Read Press Release|
Wednesday, March 18, 2009

FIRMAGON® (degarelix) is launched in Europe for the treatment of advanced prostate cancer

|Read Press Release|
Thursday, February 19, 2009

European Commission grants Ferring Pharmaceuticals approval of FIRMAGON® (degarelix) for treatment of prostate cancer

|Read Press Release|
Thursday, February 19, 2009

Ferring Pharmaceuticals Creates Executive Board

|Read Press Release|
Thursday, January 22, 2009

Ferring Pharmaceuticals donates $1 million to McGill University

|Read Press Release|
Thursday, January 22, 2009

Ferring Pharmaceuticals fait un don d’1 million à l’université McGill

|Read Press Release|
Wednesday, December 24, 2008

FDA Approves Ferring Pharmaceuticals Degarelix

|Read Press Release|
Thursday, December 18, 2008

Committee for Medicinal Products for Human Use (CHMP) recommends granting marketing authorisation for FIRMAGON (degarelix) for treatment of prostate cancer

|Read Press Release|
Wednesday, December 10, 2008

Ferring and Conaris complete license agreement for new recombinant molecule in gastroenterology

|Read Press Release|
Wednesday, December 03, 2008

Ferring signs distribution agreement with BioGaia in Ireland and the Middle East.

|Read Press Release|
Monday, December 01, 2008

Auxilium Pharmaceuticals, Inc. Announces Distribution and License Agreement for Testim® in Europe with Ferring Pharmaceuticals

|Read Press Release|
Thursday, March 27, 2008

Positive phase III data unveiled for new GnRH blocker degarelix

|Read Press Release|
Thursday, February 28, 2008

Ferring submits new drug application for degarelix, a prostate cancer treatment

|Read Press Release|
Wednesday, January 30, 2008

Launch of new infertility and gynaecology research grant (FRIGGA)

|Read Press Release|
Monday, December 03, 2007

Ferring pharmaceuticals completes phase III study of degarelix in prostate cancer patients

|Read Press Release|
Tuesday, October 30, 2007

Superior remission rates for once daily use of Pentasa® (mesalazine) in

|Read Press Release|
Thursday, October 11, 2007

Ferring Pharmaceuticals Forges Worldwide Licensing Agreement for Budesonide MMX™

|Read Press Release|
Tuesday, September 25, 2007

Ferring Pharmaceuticals Announces Board Changes

|Read Press Release|
Monday, July 02, 2007

Inequality in treatment access remains a key issue for infertile couples across Europe

|Read Press Release|
Monday, July 02, 2007

New data demonstrates both cost and efficacy benefit of MENOPUR® compared to recombinant FSH treatment

|Read Press Release|
Friday, November 17, 2006

DONGBAO TO ACQUIRE FERRING'S MALMÖ MANUFACTURING OPERATION

|Read Press Release|
Tuesday, October 24, 2006

Potential of mesalazine to prevent colorectal cancer in IBD

|Read Press Release|
Thursday, July 06, 2006

Ferring Pharmaceuticals Officially Opens Its Production Site and Global Administrative Headquarters

|Read Press Release|
Monday, June 19, 2006

Assisted Reproductive Technology helps address demographic challenge in Europe

|Read Press Release|
Friday, April 07, 2006

Degarelix, a novel GnRH blocker from Ferring, moves into phase III

|Read Press Release|
Tuesday, January 31, 2006

Ferring and Astellas enter a license agreement on Degarelix for the treatment of prostate cancer in Japan

|Read Press Release|
Thursday, September 01, 2005

Leading urology experts call for better recognition and treatment of nocturia

|Read Press Release|
Tuesday, July 19, 2005

Ferring acquires Savient Pharmaceuticals, Inc’s global biologics manufacturing business

|Read Press Release|
Sunday, May 01, 2005

Jens Peter Nørgaard awarded prestigious professorship at University of Lund

|Read Press Release|
Tuesday, April 05, 2005

Ferring A/S offentliggør lukning af produktionsstedet Vanløse ved udgangen af 2008

|Read Press Release|
Wednesday, March 30, 2005

Grand Opening of Ferring Pharmaceuticals (China) Co Ltd - Zhongshan Manufacturing Site

|Read Press Release|
Tuesday, February 08, 2005

Ferring strengthens its infertility portfolio through agreement with Metris Therapeutics for Vorozole

|Read Press Release|
Thursday, February 03, 2005

Prestigious ICIQ meeting held at FIC

|Read Press Release|
Friday, January 28, 2005

Interview with Ferring’s Executive Chairman marks the first year with the Ferring Philosophy

|Read Press Release|
Wednesday, December 01, 2004

New ferring.com goes live

|Read Press Release|
Wednesday, October 20, 2004

Mrs. Eva Paulsen, Ferring co-Founder, dies at 86

|Read Press Release|
Tuesday, October 05, 2004

Degarelix, a new GnRH blocker from Ferring, shows rapid onset and sustained activity in a phase II clinical study in men with prostate cancer

|Read Press Release|
Thursday, August 26, 2004

Volume of urine as a useful indicator of Nocturnal Polyuria

|Read Press Release|
Sunday, August 01, 2004

New nocturia section launched on MINIRIN.com

|Read Press Release|
Tuesday, June 29, 2004

Experts confirm LH activity as an essential component in infertility treatment

|Read Press Release|
Tuesday, June 29, 2004

Ferring Kicks Off Campaign for Newest Product NORPROLAC at the International ESHRE Conference in Ber

|Read Press Release|
Thursday, June 17, 2004

International experts recommend that children who want to be treated for bedwetting should be offere

|Read Press Release|
Monday, May 10, 2004

Study reveals that women undergoing a cycle of IVF treatment with MENOPUR may have a significantly i

|Read Press Release|
Friday, April 02, 2004

Ferring appoints President of the Ferring Research Institute

|Read Press Release|
Monday, March 15, 2004

Dr Eberhard Zinn Ferring Board Member dies at 66

|Read Press Release|
Friday, February 27, 2004

Research by 2003 Nobel Laureate in Chemistry Fills in ‘Scientific Gaps’ Necessary for Ferring Resear

|Read Press Release|
Thursday, January 22, 2004

Updates in Infertility Congress

|Read Press Release|
Thursday, January 22, 2004

Additional data from a large multi-national trial indicates that women undergoing IVF treatment with MENOPUR have a significantly improved chance of becoming pregnant

|Read Press Release|
Monday, January 12, 2004

Ferring Acquires DUPOMAR

|Read Press Release|
Tuesday, January 06, 2004

Ferring Acquires NORPROLAC

|Read Press Release|
Friday, November 28, 2003

New Evidence Shows incidence of Colo-rectal Cancer may be Reduced in Patients with Ulcerative Coliti

|Read Press Release|
Wednesday, October 15, 2003

New infertility study - Significant difference between treatments

|Read Press Release|
Monday, September 22, 2003

Ferring grants Dr. Frederik Paulsen Memorial Award in Japan

|Read Press Release|
Friday, September 12, 2003

Ferring Pharmaceuticals to build state of the art production site in Saint-Prex

|Read Press Release|
Sunday, June 29, 2003

The Incredible Egg

|Read Press Release|
Friday, June 06, 2003

Counting the Costs of Nightly Visits to the Bathroom

|Read Press Release|
Wednesday, June 04, 2003

Her Majesty the Queen of Sweden Addresses Salk Institute Meeting on Childhood Diseases in Stockholm

|Read Press Release|
Friday, April 11, 2003

Ferring building receives award

|Read Press Release|
Tuesday, March 18, 2003

Ferring featured in the American Medical Review ™ television series

|Read Press Release|
Monday, March 03, 2003

New website about primary nocturnal enuresis opened in Scandinavia

|Read Press Release|
Friday, November 08, 2002

5-ASAs-mesalazine May Lower Colorectal Cancer Risk in Inflammatory Bowel Disease (IBD)

|Read Press Release|
Wednesday, October 30, 2002

Ferring and Johnson and Johnson Join in a Research Collaboration

|Read Press Release|
Wednesday, October 02, 2002

Ferring appoints new Board Member

|Read Press Release|
Tuesday, October 01, 2002

Ferring Pharmaceuticals and Beth Israel Deaconess Medical Center Announce Drug Discovery Collaborati

|Read Press Release|
Tuesday, October 01, 2002

Ferring Appoints New Vice-President of Global Marketing

|Read Press Release|
Thursday, May 16, 2002

Taking the Needle Out of the Injection

|Read Press Release|
Monday, May 13, 2002

Ferring Appoints New Board Member

|Read Press Release|
Monday, May 06, 2002

FDA APPROVES BRAVELLE

|Read Press Release|
Thursday, March 21, 2002

Building for the 21st Century

|Read Press Release|
Friday, February 22, 2002

First international consultation on nocturia sheds light on neglected disease area

|Read Press Release|
Wednesday, January 23, 2002

Advances In Infertility

|Read Press Release|
Tuesday, January 08, 2002

New Ferring International Center opens for business

|Read Press Release|
 

By using the service, you agree to the following:

Your email address and the recipient's email address will be used for transmission purposes only - to inform the addressee about the sender, or for sending a message in the event of a transmission error. Both email addresses will be deleted from our system after a short period.

Print

Share this page

© Ferring 2012